{"id":16038,"date":"2023-10-26T10:00:20","date_gmt":"2023-10-26T08:00:20","guid":{"rendered":"https:\/\/world-heart-federation.org\/?post_type=resource&#038;p=16038"},"modified":"2023-10-27T12:18:45","modified_gmt":"2023-10-27T10:18:45","slug":"whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary","status":"publish","type":"resource","link":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/","title":{"rendered":"Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":16040,"template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"event":[],"project-campaign":[],"topic":[355,166],"class_list":["post-16038","resource","type-resource","status-publish","has-post-thumbnail","hentry"],"acf":{"download_counter":167,"last_downloaded":"2024-12-03 08:33:31"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.9 (Yoast SEO v23.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/\" \/>\n<meta property=\"og:site_name\" content=\"World Heart Federation\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-27T10:18:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/world-heart-federation.org\/wp-content\/uploads\/ATTR-CM-722x1024.png\" \/>\n\t<meta property=\"og:image:width\" content=\"722\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/\",\"url\":\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/\",\"name\":\"Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)\",\"isPartOf\":{\"@id\":\"https:\/\/world-heart-federation.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/world-heart-federation.org\/wp-content\/uploads\/ATTR-CM.png\",\"datePublished\":\"2023-10-26T08:00:20+00:00\",\"dateModified\":\"2023-10-27T10:18:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#primaryimage\",\"url\":\"https:\/\/world-heart-federation.org\/wp-content\/uploads\/ATTR-CM.png\",\"contentUrl\":\"https:\/\/world-heart-federation.org\/wp-content\/uploads\/ATTR-CM.png\",\"width\":1249,\"height\":1772},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/world-heart-federation.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Resources\",\"item\":\"https:\/\/world-heart-federation.org\/resource\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/world-heart-federation.org\/#website\",\"url\":\"https:\/\/world-heart-federation.org\/\",\"name\":\"World Heart Federation\",\"description\":\"Cardiovascular Health for Everyone\",\"publisher\":{\"@id\":\"https:\/\/world-heart-federation.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/world-heart-federation.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/world-heart-federation.org\/#organization\",\"name\":\"World Heart Federation\",\"url\":\"https:\/\/world-heart-federation.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/world-heart-federation.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/world-heart-federation.org\/wp-content\/uploads\/2021\/02\/main-logo.svg\",\"contentUrl\":\"https:\/\/world-heart-federation.org\/wp-content\/uploads\/2021\/02\/main-logo.svg\",\"width\":183,\"height\":59,\"caption\":\"World Heart Federation\"},\"image\":{\"@id\":\"https:\/\/world-heart-federation.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/","og_locale":"en_GB","og_type":"article","og_title":"Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)","og_url":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/","og_site_name":"World Heart Federation","article_modified_time":"2023-10-27T10:18:45+00:00","og_image":[{"width":722,"height":1024,"url":"https:\/\/world-heart-federation.org\/wp-content\/uploads\/ATTR-CM-722x1024.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/","url":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/","name":"Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)","isPartOf":{"@id":"https:\/\/world-heart-federation.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#primaryimage"},"image":{"@id":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#primaryimage"},"thumbnailUrl":"https:\/\/world-heart-federation.org\/wp-content\/uploads\/ATTR-CM.png","datePublished":"2023-10-26T08:00:20+00:00","dateModified":"2023-10-27T10:18:45+00:00","breadcrumb":{"@id":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#primaryimage","url":"https:\/\/world-heart-federation.org\/wp-content\/uploads\/ATTR-CM.png","contentUrl":"https:\/\/world-heart-federation.org\/wp-content\/uploads\/ATTR-CM.png","width":1249,"height":1772},{"@type":"BreadcrumbList","@id":"https:\/\/world-heart-federation.org\/resource\/whf-consensus-on-transthyretin-amyloidosis-cardiomyopathy-policy-summary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/world-heart-federation.org\/"},{"@type":"ListItem","position":2,"name":"Resources","item":"https:\/\/world-heart-federation.org\/resource\/"},{"@type":"ListItem","position":3,"name":"Policy Summary of the WHF Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)"}]},{"@type":"WebSite","@id":"https:\/\/world-heart-federation.org\/#website","url":"https:\/\/world-heart-federation.org\/","name":"World Heart Federation","description":"Cardiovascular Health for Everyone","publisher":{"@id":"https:\/\/world-heart-federation.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/world-heart-federation.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/world-heart-federation.org\/#organization","name":"World Heart Federation","url":"https:\/\/world-heart-federation.org\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/world-heart-federation.org\/#\/schema\/logo\/image\/","url":"https:\/\/world-heart-federation.org\/wp-content\/uploads\/2021\/02\/main-logo.svg","contentUrl":"https:\/\/world-heart-federation.org\/wp-content\/uploads\/2021\/02\/main-logo.svg","width":183,"height":59,"caption":"World Heart Federation"},"image":{"@id":"https:\/\/world-heart-federation.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/resource\/16038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/types\/resource"}],"version-history":[{"count":2,"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/resource\/16038\/revisions"}],"predecessor-version":[{"id":16043,"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/resource\/16038\/revisions\/16043"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/media\/16040"}],"wp:attachment":[{"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/media?parent=16038"}],"wp:term":[{"taxonomy":"event","embeddable":true,"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/event?post=16038"},{"taxonomy":"project-campaign","embeddable":true,"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/project-campaign?post=16038"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/world-heart-federation.org\/wp-json\/wp\/v2\/topic?post=16038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}